Your browser doesn't support javascript.
Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers.
Yang, Qing; Meyerson, Nicholas R; Clark, Stephen K; Paige, Camille L; Fattor, Will T; Gilchrist, Alison R; Barbachano-Guerrero, Arturo; Healy, Benjamin G; Worden-Sapper, Emma R; Wu, Sharon S; Muhlrad, Denise; Decker, Carolyn J; Saldi, Tassa K; Lasda, Erika; Gonzales, Patrick; Fink, Morgan R; Tat, Kimngan L; Hager, Cole R; Davis, Jack C; Ozeroff, Christopher D; Brisson, Gloria R; McQueen, Matthew B; Leinwand, Leslie A; Parker, Roy; Sawyer, Sara L.
  • Yang Q; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Meyerson NR; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States.
  • Clark SK; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Paige CL; Darwin Biosciences Inc, Boulder, United States.
  • Fattor WT; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Gilchrist AR; Darwin Biosciences Inc, Boulder, United States.
  • Barbachano-Guerrero A; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Healy BG; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Worden-Sapper ER; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Wu SS; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States.
  • Muhlrad D; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Decker CJ; Department of Mechanical Engineering, University of Colorado Boulder, Boulder, United States.
  • Saldi TK; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Lasda E; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States.
  • Gonzales P; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Fink MR; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States.
  • Tat KL; Interdisciplinary Quantitative Biology Graduate Program, University of Colorado Boulder, Boulder, United States.
  • Hager CR; Department of Biochemistry, University of Colorado Boulder, Boulder, United States.
  • Davis JC; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, United States.
  • Ozeroff CD; Department of Biochemistry, University of Colorado Boulder, Boulder, United States.
  • Brisson GR; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, United States.
  • McQueen MB; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Leinwand LA; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Parker R; BioFrontiers Institute, University of Colorado Boulder, Boulder, United States.
  • Sawyer SL; Department of Integrative Physiology, University of Colorado Boulder, Boulder, United States.
Elife ; 102021 03 29.
Article in English | MEDLINE | ID: covidwho-1156211
ABSTRACT
Here, we develop a simple molecular test for SARS-CoV-2 in saliva based on reverse transcription loop-mediated isothermal amplification. The test has two

steps:

(1) heat saliva with a stabilization solution and (2) detect virus by incubating with a primer/enzyme mix. After incubation, saliva samples containing the SARS-CoV-2 genome turn bright yellow. Because this test is pH dependent, it can react falsely to some naturally acidic saliva samples. We report unique saliva stabilization protocols that rendered 295 healthy saliva samples compatible with the test, producing zero false positives. We also evaluated the test on 278 saliva samples from individuals who were infected with SARS-CoV-2 but had no symptoms at the time of saliva collection, and from 54 matched pairs of saliva and anterior nasal samples from infected individuals. The Saliva TwoStep test described herein identified infections with 94% sensitivity and >99% specificity in individuals with sub-clinical (asymptomatic or pre-symptomatic) infections.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Saliva / Carrier State / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: ELife.65113

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Saliva / Carrier State / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: ELife.65113